Global Strategy
Kowa's pharmaceutical business is global, with offices in the United States, Europe and Asia. With a commitment to ground-breaking research, development and marketing, we ensure steady supply of products with quality and reliability to help people around the world enjoy better health.
Livalo® is a prescription drug for the treatment of dyslipidemia developed in Japan by Kowa and with its proven efficacy it has grown into our global product currently marketed in the United States and Asia.
Further launches are expected in Europe and other regions in the near future.
USA
![Kowa Pharmaceuticals America, Inc.](../../../img/international/national03.jpg)
Kowa Pharmaceuticals America, Inc.
Sales and marketing
![Kowa Research Institute, Inc.](../../../img/international/national03.jpg)
Research and development
![Center for Interdisciplinary Cardiovascular Sciences](../../../img/international/national03.jpg)
Center for Interdisciplinary Cardiovascular Sciences
Research
Europe
![Kowa Pharmaceutical Europe AG](../../../img/international/national01.jpg)
Kowa Pharmaceutical Europe AG
Administration center, Research and development
![Kowa Pharmaceutical Europe Co. Ltd.](../../../img/international/national02.jpg)
Kowa Pharmaceutical Europe Co. Ltd.
Sales and marketing
Asia
![Kowa Pharmaceutical Asia Pte. Ltd.](../../../img/international/national04.jpg)
Kowa Pharmaceutical Asia Pte. Ltd.
Administration center, Research and development
![Kowa Pharmaceuticals (China) Co., Ltd.](../../../img/international/national05.jpg)
Kowa Pharmaceuticals (China) Co., Ltd.
Sales and marketing, Manufacture
![Kowa Korea Company, Ltd.](../../../img/international/national06.jpg)
Sales and marketing
![Kowa Taiwan Tsusho Co., Ltd.](../../../img/international/national07.jpg)
Sales and marketing
![Kowa (Thailand) Co., Ltd.](../../../img/international/national08.jpg)
Sales and marketing